These results indicate that, although the overall amount of CLDN4 in pancreatic cancer and normal pancreatic tissue is nearly the same, CLDN4 is superficially exposed in pancreatic cancer compared with the normal pancreas owing to disruption of tight junctions. This evidence concerns the gene CLDN4 and familial pancreatic carcinoma.